These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1670 related articles for article (PubMed ID: 32011647)

  • 41. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
    Dager WE
    Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Case-control study on three antithrombotic agents for the prevention of venous thromboembolism after unilateral total knee arthroplasty].
    Miao SG; Zhang XG; Lu JH; Yang Y; Lu N
    Zhongguo Gu Shang; 2015 Oct; 28(10):893-6. PubMed ID: 26727779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.
    Kapoor A; Chuang W; Radhakrishnan N; Smith KJ; Berlowitz D; Segal JB; Katz JN; Losina E
    Pharmacoeconomics; 2010; 28(7):521-38. PubMed ID: 20550220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis.
    Kapoor A; Ellis A; Shaffer N; Gurwitz J; Chandramohan A; Saulino J; Ishak A; Okubanjo T; Michota F; Hylek E; Trikalinos TA
    J Thromb Haemost; 2017 Feb; 15(2):284-294. PubMed ID: 28102615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison between use of direct oral anticoagulants and aspirin for risk of thromboembolism complications in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis.
    Cai JY; Cui CM; Min JK; Cao YQ; Zhang LY
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6245-6259. PubMed ID: 34730204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Venous thromboembolism prophylaxis strategies for people undergoing elective total knee replacement: a systematic review and network meta-analysis.
    Lewis S; Glen J; Dawoud D; Dias S; Cobb J; Griffin XL; Rossiter N; Reed M; Sharpin C; Stansby G; Barry P
    Lancet Haematol; 2019 Oct; 6(10):e530-e539. PubMed ID: 31444124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty.
    Lussana F; Squizzato A; Permunian ET; Cattaneo M
    Thromb Res; 2014 Sep; 134(3):599-603. PubMed ID: 25064034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Temporal trends in pharmacologic prophylaxis for venous thromboembolism after hip and knee replacement in older adults.
    Ko D; Kapoor A; Rose AJ; Hanchate AD; Miller D; Winter MR; Palmisano JN; Henault LE; Fredman L; Walkey AJ; Tripodis Y; Karcz A; Hylek EM
    Vasc Med; 2020 Oct; 25(5):450-459. PubMed ID: 32516054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip Replacement: A Systematic Review and Network Meta-Analysis.
    Lewis S; Glen J; Dawoud D; Dias S; Cobb J; Griffin X; Reed M; Sharpin C; Stansby G; Barry P
    Value Health; 2019 Aug; 22(8):953-969. PubMed ID: 31426937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence and risk factors associated with venous thromboembolism following primary total hip arthroplasty in low-risk patients when using aspirin for prophylaxis.
    Howard TA; Judd CS; Snowden GT; Lambert RJ; Clement ND
    Hip Int; 2022 Sep; 32(5):562-567. PubMed ID: 33594900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
    Chu JN; Maselli J; Auerbach AD; Fang MC
    Thromb Res; 2017 Jul; 155():65-71. PubMed ID: 28501678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
    Goel R; Fleischman AN; Tan T; Sterbis E; Huang R; Higuera C; Parvizi J; Rothman RH
    Bone Joint J; 2018 Jan; 100-B(1 Supple A):68-75. PubMed ID: 29292343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer's perspective.
    Duran A; Sengupta N; Diamantopoulos A; Forster F; Kwong L; Lees M
    Pharmacoeconomics; 2012 Feb; 30(2):87-101. PubMed ID: 22187932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
    Johnson SA; Jones AE; Young E; Jennings C; Simon K; Fleming RP; Witt DM
    Thromb Res; 2021 Oct; 206():120-127. PubMed ID: 34455129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting.
    McCullagh L; Tilson L; Walsh C; Barry M
    Pharmacoeconomics; 2009; 27(10):829-46. PubMed ID: 19803538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
    Bala A; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF
    Clin Orthop Relat Res; 2017 Sep; 475(9):2205-2213. PubMed ID: 28569372
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 84.